Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Karyopharm Therapeut
(NQ:
KPTI
)
0.8335
+0.0463 (+5.88%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
546,298
Open
0.8000
Bid (Size)
0.8200 (35)
Ask (Size)
0.8400 (68)
Prev. Close
0.7872
Today's Range
0.7900 - 0.8360
52wk Range
0.6174 - 1.950
Shares Outstanding
114,010,448
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript
August 06, 2024
KPTI earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
KPTI Stock Earnings: Karyopharm Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
KPTI stock results show that Karyopharm Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-7.51%
-7.51%
1 Month
-13.20%
-13.20%
3 Month
-16.10%
-16.10%
6 Month
-36.37%
-36.37%
1 Year
-42.12%
-42.12%
More News
Read More
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
May 23, 2024
Via
InvestorPlace
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
May 08, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
KPTI Stock Earnings: Karyopharm Therapeutics Beats EPS, Misses Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript
February 29, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Earnings Scheduled For February 29, 2024
February 29, 2024
Via
Benzinga
Karyopharm Therapeutics's Earnings: A Preview
February 28, 2024
Via
Benzinga
Earnings Preview For Karyopharm Therapeutics
November 01, 2023
Via
Benzinga
6 Analysts Have This to Say About Karyopharm Therapeutics
August 03, 2023
Via
Benzinga
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
February 25, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 31, 2024
Via
Benzinga
Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript
November 02, 2023
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks That Hit 52-Week Lows On Wednesday
August 30, 2023
Via
Benzinga
Karyopharm Therapeutics (KPTI) Q2 2023 Earnings Call Transcript
August 02, 2023
Via
The Motley Fool
Karyopharm's Selinexor Shows Progression-Free Survival of 27.4 Months In Endometrial Cancer With Certain Mutation
July 26, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 18, 2023
Via
Benzinga
CMG Stock Alert: Chipotle Announces International Expansion Plan
July 18, 2023
Via
InvestorPlace
Why Are Karyopharm Therapeutics Shares Gaining Today?
July 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 18, 2023
Via
Benzinga
Why Is CEL-SCI (CVM) Stock Down 23% Today?
July 18, 2023
Via
InvestorPlace
Why Is Masimo (MASI) Stock Down 30% Today?
July 18, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.